Platform - IsoPlexis Solutions
After the CAR-T cells are produced, there are still challenges in determining effectiveness. The single-cell functional proteomics platform from IsoPlexis, however, helps a researcher assess the true function of their engineered cell products. Specifically, it reveals polyfunctional T cells, which produce two or more cytokines simultaneously. The IsoPlexis technology captures the highly multiplexed cytokine signatures from each cell, revealing the unique power of the individual supercell.
KCAS is ready to put the IsoPlexis to work for your project
KCAS can identify the most potent and effective cells within a CAR-T cell product. Our customers can use this data to compare the results of different methods of preparing therapeutic T cells. Then, a method can be optimized to produce CAR-T cells that exhibit the desired properties.